14th European Breast Cancer Conference
Welcome to Sysmex Life Science at the EBCC 2024 in Italy!
At Sysmex Life Science, we are on a mission to enhance the healthcare journey for those affected by breast cancer.
Discover the future of breast cancer solutions at booth #7:
Join us in an immersive journey where precision meets innovation, so that patient care can reach new heights. As a token of our appreciation, we invite you to indulge in a delightful experience – pick up your free ice cream while encountering the cutting-edge advancements in breast cancer diagnostics.
Explore our leading-edge solutions and delve into the world of MammaTyper®, OSNA, and CytoCell® (FISH) – technologies meticulously crafted to elevate the accuracy and efficiency of breast cancer diagnostics. Uncover the potential of liquid biopsy, a groundbreaking approach revolutionising monitoring and personalised care in breast cancer.
Engage with our experts on site and let them guide you through how Sysmex Life Science is shaping the future of breast cancer diagnostics and monitoring.
Partners in excellence:
Visit our neighbour Cerca Biotech at booth #8!
We are thrilled to share the EBCC space with our esteemed partner, Cerca Biotech, who will give you further insights on MammaTyper®, designed for comprehensive molecular subtyping based on mRNA expression. Witness the synergy of our expertise as partners in excellence.
Don’t miss this exclusive opportunity to gain first-hand insights and perspectives at our Industry Forum. Sysmex Life Science is dedicated to pushing boundaries, and we invite you to be a part of the conversation.
And remember:
Join us at booth #7 for an unforgettable experience and engage with our experts on site. We look forward to seeing you there!
Workshops
| Time | Title | Speaker |
|---|---|---|
| 16:50-16:53 | Introduction to the industry forum | Chair: Prof. Nicola Fusco |
| 16:53-17:00 | HER2-low breast cancer | Dr Carolien van Deurzen, Erasmus University Medical Center Rotterdam, The Netherlands |
| 17:00-17:07 | Risk stratification and circulating biomarkers | Prof Nicola Fusco, European Institute of Oncology, University of Milan, Italy |
| 17:07-17:10 | How do Sysmex diagnostic solutions support the healthcare journey in breast cancer? | Dr Marta Marszalkowska, Sysmex Europe SE, Germany |
| 17:10-17:15 | Q&A | Chair: Prof. Nicola Fusco |